TIMOLOL MALEATE

Post-LOE

timolol maleate

ANDAOPHTHALMICSOLUTION/DROPS
Approved
May 2023
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
7

Clinical Trials (5)

NCT04742283Phase 2Completed

Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension

Started Dec 2020
323 enrolled
Primary Open Angle GlaucomaOcular Hypertension
NCT03691662Phase 3Completed

A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 4 Study

Started Sep 2018
417 enrolled
Glaucoma and Ocular Hypertension
NCT03691649Phase 3Completed

A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study

Started Sep 2018
426 enrolled
Glaucoma and Ocular Hypertension
NCT03519386Phase 3Completed

Randomized Study Comparing Two Models of a Travoprost Intraocular Implant to Timolol Maleate Ophthalmic Solution, 0.5%

Started Jul 2018
NCT01749904Phase 3Completed

Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Started Jan 2013
420 enrolled
Open-Angle GlaucomaOcular Hypertension